The value of adding MRI to a clinical Treat-To-Target strategy in rheumatoid arthritis patients in clinical remission: Clinical and radiographic outcomes from the IMGINE-RA randomized controlled trial
- Signe Møller-Bisgaard (Speaker)
- Kim Hørslev-Petersen (Speaker)
- Bo Jannik Ejbjerg (Speaker)
- Merete Lund Hetland (Speaker)
- Lykke Midtbøll Ørnbjerg (Speaker)
- Daniel Glinatski (Speaker)
- J. Møller (Speaker)
- Michael Boesen (Speaker)
- R Christensen (Speaker)
- Kristian Stengaard-Pedersen (Speaker)
- Ole Rintek Madsen (Speaker)
- B. Jensen (Speaker)
- Jan Alexander Villadsen (Speaker)
- Ellen Margrethe Hauge (Speaker)
- Philip Bennett (Speaker)
- Hendricks, O. (Speaker)
- Karsten Asmussen (Speaker)
- Marcin Ryszard Kowalski (Speaker)
- Hanne Lindegaard (Speaker)
- Mai Nielsen, S. (Speaker)
- Henning Bliddal (Speaker)
- N Krogh (Speaker)
- Ellingsen, T. J. (Speaker)
- AH Nielsen (Speaker)
- Lone Balding (Speaker)
- Anne Grethe Jurik (Speaker)
- H. Thomsen (Speaker)
- Mikkel Østergaard (Speaker)
Activity: Talks and presentations › Conference presentations